MiMedx Awarded Six New U.S. Patents This Year

MiMedx

MARIETTA, Ga., Aug. 29, 2016 /PRNewswire/ — MiMedx Group, Inc. (NASDAQ: MDXG), the leading regenerative medicine company utilizing human amniotic tissue and patent-protected processes to develop and market advanced products and therapies for the Wound Care, Surgical, Orthopedic, Spine, Sports Medicine, Ophthalmic, and Dental sectors of healthcare, announced today an update to  its intellectual property portfolio.…

Read More

World’s First Human Head Transplant Procedure Planned in 2017

Head Transplant

Italian neurosurgeon Sergio Canavero is planning to perform the first-ever head transplant in December 2017. He will put the head of a terminally ill, wheelchair-bound Russian citizen Valery Spiridonov (31) on an entirely new body. Spiridonov, a computer scientist, has Werdnig-Hoffman disease, a rare and incurable spinal muscular atrophy. As the disease is sure to…

Read More

Dominant Robotic Surgery Patents Expiring This Year. What’s Coming Next?

Robotic Surgery

Patents are essential to encouraging innovation, but can also limit competition. Intuitive Surgical has dominated the global robotic surgery market (which is expected to hit $11.4 billion by 2020) since the FDA approved its Da Vinci surgical system 16 years ago; today, the machine is used in more than 200,000 operations annually. But many of Intuitive Surgical’s patents begin…

Read More

Bio2 Medical Announces 510(k) Clearance for the First Ever Angel® Catheter

510(k) clearance

GOLDEN, Colo., Aug. 24, 2016 /PRNewswire/ — Bio2 Medical is pleased to announce the Angel® Catheter has received 510(k) clearance from the United States Food & Drug Administration (FDA). This 510(k) clearance includes a first ever, prophylactic indication for a medical device to protect critically ill patients at high-risk for pulmonary embolism (PE) and contraindicated…

Read More

Precision Test For Breast Cancer Treatment Remains Imprecise

breast cancer

A major study about the best way to treat early-stage breast cancer reveals that “precision medicine” doesn’t provide unambiguous answers about how to choose the best therapy. “Precision doesn’t mean certainty,” says David Hunter, a professor of cancer prevention at Harvard’s T.H. Chan School of Public Health. That point is illustrated in a large study…

Read More

New Regenerative Bandage Heals Wounds Faster for Diabetes

diabetes

At some point in their lives, 15 percent of people with diabetes will develop a painful and hard-to-treat foot ulcer. Twenty-four percent of those affected will require a lower-leg amputation because of it. And, in some instances, what seems like a harmless sore might even lead to death. A Northwestern Engineering team has developed a…

Read More

Mallinckrodt to Sell Nuclear Imaging Business to IBA Molecular for $690 Million

Nuclear Imaging

Mallinckrodt Pharmaceuticals announced Aug. 24 it has reached an agreement to sell its nuclear imaging business to IBA Molecular (IBAM) for $690 million. “Our team has made significant progress in driving profitability over the past few years,” said Mark Trudeau, Mallinckrodt President and CEO, in a statement. “But with our strategic priorities focused on enlarging…

Read More

Read these 5 Undeniable reasons why you need to follow your favorite recruiter(s) on Twitter today!

Twitter

As a woman who grew up in the “8 track-player” era, the whole SnapChat, Instagram, Facebook world has taken a little getting used to. I laughed when Twitter first hit the scene… and yet now, I use it as a major source for reading breaking medical news, following our clients and their competitors, sharing our…

Read More

Doctors Stand to Lose Incentive Payments Due to Unrealistic Quality Standards

incentive payments

The doctors staffing New York City’s public hospitals stand to lose out on tens of thousands of dollars in incentive payments because of new standards they say are too high.   As part of the doctors’ most recent contract with NYC Health & Hospitals, agreed to last summer, 5% of physicians’ payments from the municipal…

Read More

Study Of Sudden Heart Death Exposes Limits Of Genetic Testing 

Sudden Heart Death

Scientists have discovered that a common cause of sudden heart death has been misunderstood because researchers didn’t appropriately account for racial differences in their studies. The findings, published online Wednesday in the New England Journal of Medicine,have implications far beyond this particular inherited disease, called hypertrophic cardiomyopathy, or HCM. Researchers say the results also sound…

Read More